French drugmaker Sanofi reported a fourth-quarter profit that came in-line with analysts' estimates on Thursday, and said it ...
Snapshot of the implementation used to generate figures and numerical results from the paper "Sharp Bounds for Continuous-Valued Treatment Effects with Unobserved ...
Analyst Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report) and keeping the price target at €122.00. Discover top-rated stocks from highly ...
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Sanofi (SNYNF – Research Report), with a price target of €105.00. The company’s shares closed ...